A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy.
A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy.
复制标题
外泌体介导的药物外排和扰动诱导的协同作用的定量药理学模型。
DOI:
10.3390/pharmaceutics13070997
复制
发表时间:
2021-06-30
期刊:
影响因子:
5.4
通讯作者:
Au JL
中科院分区:
文献类型:
--
作者:
Wang J;Yeung BZ;Wientjes MG;Cui M;Peer CJ;Lu Z;Figg WD;Woo S;Au JL
Exosomes, naturally occurring vesicles secreted by cells, are undergoing development as drug carriers. We used experimental and computational studies to investigate the kinetics of intracellular exosome processing and exosome-mediated drug efflux and the effects of exosome inhibition. The experiments used four human-breast or ovarian cancer cells, a cytotoxic drug paclitaxel (PTX), two exosome inhibitors (omeprazole (OME), which inhibits exosome release, and GW4869 (GW), which inhibits synthesis of sphingolipid ceramide required for exosome formation), LC-MS/MS analysis of PTX levels in exosomes, and confocal microscopic study of endocytic transport (monitored using fluorescent nanoparticles and endocytic organelle markers). In all four cells, exosome production was enhanced by PTX but diminished by OME or GW (p < 0.05); the PTX enhancement was completely reversed by OME or GW. Co-treatment with OME or GW simultaneously reduced PTX amount in exosomes and increased PTX amount and cytotoxicity in exosome-donor cells (corresponding to >2-fold synergy as indicated by curve shift and uncertainty envelope analyses). This synergy is consistent with the previous reports that OME co-administration significantly enhances the taxane activity in tumor-bearing mice and in patients with triple negative metastatic breast cancer. The experimental results were used to develop a quantitative pharmacology model; model simulations revealed the different effects of the two exosome inhibitors on intracellular PTX processing and subcellular distribution.
登录
查看更多内容
影响因子:
50.3
作者:
Hu G;Chong RA;Yang Q;Wei Y;Blanco MA;Li F;Reiss M;Au JL;Haffty BG;Kang Y
通讯作者:
Kang Y
DOI:
10.1016/j.apsb.2016.02.001
发表时间:
2016-07
期刊:
Acta pharmaceutica Sinica. B
影响因子:
--
作者:
Ha D;Yang N;Nadithe V
通讯作者:
Nadithe V
影响因子:
16.1
作者:
Li, Yinghuan;Wang, Jie;Wientjes, M. Guillaume;Au, Jessie L. -S.
通讯作者:
Au, Jessie L. -S.
影响因子:
46.2
作者:
Behzadi S;Serpooshan V;Tao W;Hamaly MA;Alkawareek MY;Dreaden EC;Brown D;Alkilany AM;Farokhzad OC;Mahmoudi M
通讯作者:
Mahmoudi M
影响因子:
16.1
作者:
Au JL;Yeung BZ;Wientjes MG;Lu Z;Wientjes MG
通讯作者:
Wientjes MG